CIK: 1841401 - Address: C/O Tarsus Pharmaceuticals, Inc., 15440 Laguna Canyon Road, Suite 160, Irvine, CA 92618
11 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
3/19/24 19:05
3/15/24
TARSTarsus Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagWahl BryanCAOGCM.d00.000124241D
3/19/24 19:05
3/18/24
TARSTarsus Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagWahl BryanCAOGCS.d-13630.600-4-1041D
12/1/23 16:55
11/29/23
TARSTarsus Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagWahl BryanCAOGCM.d00.0002429732D
12/1/23 16:55
11/30/23
TARSTarsus Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagWahl BryanCAOGCS.d-13616.310-8-2132D
3/23/23 19:52
3/21/23
TARSTarsus Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagWahl BryanCAOGCS.m-1412.550-1-616D
3/21/23 19:14
3/17/23
TARSTarsus Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagWahl BryanCAOGCS.m-912.940-1-417D
3/17/23 18:21
3/15/23
TARSTarsus Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagWahl BryanCAOGCM.d00.00053618D
3/17/23 18:21
3/16/23
TARSTarsus Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagWahl BryanCAOGCS.d-513.4300-218D
12/6/22 17:49
12/2/22
TARSTarsus Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagWahl BryanCAOGCS-2016.900-1-814D
12/1/22 19:58
11/29/22
TARSTarsus Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagWahl BryanCAOGCM.d00.0001022215D
12/1/22 19:58
11/30/22
TARSTarsus Pharmaceuticals, Inc.DEHealthBioPrdBiological Products, (No DiagWahl BryanCAOGCS.dm-3916.620-2-1415D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact